The Italian Patent and Trademark Office Officially Recognizes the Patent for REMaST® Therapy
The positive evaluation by the Italian Patent and Trademark Office has led to the long-awaited recognition of REMaST® therapy, two years after the patent application was submitted, marking a significant milestone in our development journey.
The patent covers the REMaST® cell therapy product, the method developed by Hemera to produce it, and its use in tissue regeneration. This achievement represents a major milestone for the company and for the entire R&D team led by Prof. Ilaria Decimo.
We are grateful to everyone who has supported us during this initial growth phase and acknowledge the importance of strategic partnerships in achieving our shared goals.
Hemera continues to develop and protect its scientific and technological know-how, investing in research and innovation.